期刊文献+

COX-2与骨代谢关系的研究进展

Research progress of the relationship between COX-2 and bone formation
下载PDF
导出
摘要 环氧化酶2(cyclooxygenase-2,COX-2)是花生四烯酸(arachidonic acid,AA)合成前列腺素E2(prostaglandin E2,PGE2)的限速酶,通过对PGE2的调控,COX-2能够对骨代谢中骨形成和骨吸收产生多种不同的作用。同时,COX-2也能通过参与多条信号转导途径,影响骨的形成,包括G蛋白α亚基(guanine nucleotide-binding proteins alpha s,Gαs)信号通路、促丝裂原激活蛋白激酶(mitogen-activated protein kinases,MAPKs)通路以及核因子受体激活物配基(receptor activator of nuclear factorκB ligand,RANKL)信号通路。COX-2的产生由多种因素诱导,并可被其抑制剂如非甾体类抗炎药(non-steroidal anti-inflammatory drugs,NSAID)抑制。这些因素能调控COX-2的产量并最终作用于骨组织。本文就COX-2与骨形成的关系及其在相关临床应用上的展望进行介绍。 [Summary] Cyelooxygenase-2 (COX-2) is the rate-limiting enzyme of arachidonic acid (AA) synthesizing prostaglandin E2 (PGE2). It has various effects on bone metabolism that stimulate both bone resorption and formation through regulation of PGE2. Meanwhile, COX-2 can work by the participation of multiple signal transduction pathways in bone formation, including Gcts signaling pathway, mitogen-activated protein kinases (MAPKs) pathway and receptor activator of nuclear factor KB ligand (RANKL) signaling pathway. COX-2 was induced by many factors, and can be inhibited by the inhibitors such as non-steroidal anti-inflammatory drugs (NSAIDs). These factors can regulate the production of COX-2 and consequently have impact on bone tissue. The main purpose of the article was to introduce the relationship between COX- 2 and bone formation and its potential clinical applications.
出处 《中国口腔颌面外科杂志》 CAS 2016年第1期83-88,共6页 China Journal of Oral and Maxillofacial Surgery
关键词 环氧化酶2 前列腺素 骨形成 成骨细胞 破骨细胞 Cyclooxygenase-2 Prostaglandin Bone formation Osteoblast Osteoclast
  • 相关文献

参考文献2

二级参考文献14

  • 1Livak KJ ,Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^-△△Ct method. Methods, 2001,25 : 402-408.
  • 2Kanernatsu M, Sato T, Takai H. Prostaglandin E2 induces expression of receptor activator of nuclear factor kappa B ligand/ osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. J Bone Miner Res,2000, 15:1321-1329.
  • 3Li XD, Tomita M, Pilbeam CC. Prostaglandin din receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo. Prostaglandins Other Lipid Mediat ,2002,67 : 173-180.
  • 4Brandstrom H, Jonson KB, Ohlsson C, et al. Regulation of osteoprotegerin mRNA Levels by prostaglandin E2 in human bone marrow stroma cells. Bioch Biophys Research Commun, 1998, 247 : 338-341.
  • 5Baylink TM, Mohan S, Fitzsimmons R J, et al. Evaluation of signal transduction mechanisms for the mitogenic effects of pmstaglandin E2 in normal human bone cells in vitro. J Bone Miner Res, 1996,11:1413-1418.
  • 6Tang CH, Yang RS, Fu WM, et al. Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase C, and c-src pathway in primary cultured rat osteoblasts. J Bio Chem, 2005, 280:22907-22916.
  • 7Kozawa O, Suzuki H, Tokuda H, et al. Interleukin-6 synthesis induced by prostaglandin E2 : cross-talk regulation by proteinkinase C . Bone, 1998, 22:355-360.
  • 8Tokuda H, Miwa M, Oiso Y, et al. Autoregulation of prostaglandin E2-induced Ca^2+ influx in osteoblast-like cells: Inhibition by self-induced activation of protein kinase C. Cell Signal, 1992,4:261-266.
  • 9Asagiri M. Autoamplification of NFATcl expression determines its essential role in bone homeostasis. J Exp Med, 2005, 202:1261-1269.
  • 10Koga T. NFAT and osterix cooperatively regulate bone formation. Nat Med, 2005, 11 : 880-885.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部